TMDX · TransMedics Group, Inc.
AI read · Neutral
The AI's read
The notes offer conflicting views of TransMedics, not new information about its sales, profit, or products. Several analysts lowered their targets, but Canaccord raised its target and 3 firms kept Buy ratings. The story reports no clear change in the company's business outlook.